Invention Grant
- Patent Title: Hybridoma clones and monoclonal antibodies to fibroblast growth factor 4
-
Application No.: US14774083Application Date: 2014-03-12
-
Publication No.: US09611319B2Publication Date: 2017-04-04
- Inventor: David Azorsa
- Applicant: The Translational Genomics Research Institute
- Applicant Address: US AZ Phoenix
- Assignee: The Translational Genomics Research Institute
- Current Assignee: The Translational Genomics Research Institute
- Current Assignee Address: US AZ Phoenix
- Agency: Booth Udall Fuller, PLC
- Agent Rodney J. Fuller
- International Application: PCT/US2014/025097 WO 20140312
- International Announcement: WO2014/165287 WO 20141009
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C12N5/07 ; C07K16/28 ; C07K16/22 ; C12N5/16
Abstract:
The present invention is directed to a monoclonal antibody that recognizes human FGFR4 in its native form. The invention is also directed to a hybridoma cell line that produces the monoclonal antibody and methods of use thereof.
Public/Granted literature
- US20160017027A1 Hybridoma Clones and Monoclonal Antibodies to Fibroblast Growth Factor 4 Public/Granted day:2016-01-21
Information query
